Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Epilepsia Open ; 6(2): 339-344, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-34033254

RESUMO

OBJECTIVE: Information to women with epilepsy on pregnancy-related antiseizure medication (ASM) issues and reliable tools for therapeutic drug monitoring (TDM) are important aspects of epilepsy care. We aimed to develop and test an online tool for patient education on pregnancy-related issues and communication with epilepsy nurses during pregnancy for women with epilepsy. METHODS: An existing national platform for online communication (1177.se) was used, and an online tool was developed by two epilepsy nurses, two neurologists, and an IT technician. The tool was launched as a complement to standard care, and patients deciding to use it were invited to participate in a survey of user experiences and knowledge questions. RESULTS: The online tool consists of two modules: one for patient education and one for TDM during pregnancy. The latter module allows scheduling of automatic reminders of blood tests that are sent to patients at set intervals. The epilepsy nurse can communicate results and suggested dose changes in the tool. A total of 48 women answered the survey: 28 had been invited to use the information module and 20 to use the TDM module. Patient experiences were generally good, and most users of the TDM module would prefer an online means of communication in future pregnancies. For epilepsy nurses, the tool provided good overview of patients currently pregnant and administrative advantages compared with traditional means of communication. SIGNIFICANCE: Online patient education and communication about TDM during pregnancy are feasible and can be a valuable part of future digitalization efforts in epilepsy care.


Assuntos
Monitoramento de Medicamentos , Epilepsia , Anticonvulsivantes/uso terapêutico , Comunicação , Monitoramento de Medicamentos/métodos , Epilepsia/tratamento farmacológico , Feminino , Humanos , Projetos Piloto , Gravidez
2.
Mol Oncol ; 15(5): 1277-1288, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33734563

RESUMO

There is a persistent variation in cancer outcomes among and within European countries suggesting (among other causes) inequalities in access to or delivery of high-quality cancer care. European policy (EU Cancer Mission and Europe's Beating Cancer Plan) is currently moving towards a mission-oriented approach addressing these inequalities. In this study, we used the quantitative and qualitative data of the Organisation of European Cancer Institutes' Accreditation and Designation Programme, relating to 40 large European cancer centres, to describe their current compliance with quality standards, to identify the hallmarks common to all centres and to show the distinctive features of Comprehensive Cancer Centres. All Comprehensive Cancer Centres and Cancer Centres accredited by the Organisation of European Cancer Institutes show good compliance with quality standards related to care, multidisciplinarity and patient centredness. However, Comprehensive Cancer Centres on average showed significantly better scores on indicators related to the volume, quality and integration of translational research, such as high-impact publications, clinical trial activity (especially in phase I and phase IIa trials) and filing more patents as early indicators of innovation. However, irrespective of their size, centres show significant variability regarding effective governance when functioning as entities within larger hospitals.


Assuntos
Institutos de Câncer , Neoplasias/terapia , Qualidade da Assistência à Saúde , Academias e Institutos/normas , Academias e Institutos/estatística & dados numéricos , Pesquisa Biomédica/organização & administração , Pesquisa Biomédica/normas , Pesquisa Biomédica/estatística & dados numéricos , Institutos de Câncer/organização & administração , Institutos de Câncer/estatística & dados numéricos , Estudos de Coortes , Europa (Continente)/epidemiologia , Humanos , Oncologia/normas , Oncologia/estatística & dados numéricos , Neoplasias/epidemiologia , Equipe de Assistência ao Paciente/organização & administração , Equipe de Assistência ao Paciente/normas , Equipe de Assistência ao Paciente/estatística & dados numéricos , Assistência Centrada no Paciente/organização & administração , Assistência Centrada no Paciente/normas , Assistência Centrada no Paciente/estatística & dados numéricos , Pesquisa Translacional Biomédica/métodos , Pesquisa Translacional Biomédica/organização & administração , Pesquisa Translacional Biomédica/estatística & dados numéricos
3.
Euro Surveill ; 23(41)2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-30326994

RESUMO

Between June-September 2018, 20 hepatitis A cases were notified in six counties in Sweden. Combined epidemiological and microbiological investigations identified imported frozen strawberries produced in Poland as the source of the outbreak. Sequence analysis confirmed the outbreak strain IB in the strawberries with 100 % identity and the respective batch was withdrawn. Sharing the sequence information internationally led to the identification of 14 additional cases in Austria, linked to strawberries from the same producer.


Assuntos
Surtos de Doenças , Doenças Transmitidas por Alimentos/virologia , Fragaria/virologia , Frutas/virologia , Vírus da Hepatite A/genética , Hepatite A/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Áustria/epidemiologia , Criança , Surtos de Doenças/estatística & dados numéricos , Feminino , Contaminação de Alimentos , Doenças Transmitidas por Alimentos/epidemiologia , Alimentos Congelados/virologia , Genótipo , Hepatite A/diagnóstico , Hepatite A/transmissão , Hepatite A/virologia , Vírus da Hepatite A/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , RNA Viral/genética , Análise de Sequência , Suécia/epidemiologia
4.
Int J Antimicrob Agents ; 51(4): 642-645, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28843819

RESUMO

Eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonisation may prevent transmission of strains between patients and reduces the risk of clinical infection. Colonisation of the throat is associated with prolonged carriage and is more difficult to eradicate. An open randomised study was conducted to evaluate two eradication protocols. Patients with pharyngeal carriage of MRSA were enrolled at six Swedish centres during 4 years. One treatment group received oral rifampicin and either clindamycin or trimethoprim/sulfamethoxazole (SXT) for 7 days in combination with nasal mupirocin. Patients in the other group were treated with nasal mupirocin only. Patients in the same household were randomised together. Both groups followed a hygiene protocol including chlorhexidine washing. Cultures from the nares, perineum and throat were taken at baseline and then at 2 weeks, 2 months and 6 months after the end of treatment. A total of 28 patients received rifampicin-based systemic antibiotics and 24 subjects received mupirocin only. At follow-up 6 months after the end of treatment, 61% of patients and 50% of households in the systemic antibiotics group had culture results negative for MRSA. Significantly less patients (12%) and households (10%) became decolonised in the group receiving topical treatment only. A combination of rifampicin and either clindamycin or SXT was more effective in eliminating pharyngeal MRSA carriage compared with topical treatment with mupirocin only.


Assuntos
Clindamicina/uso terapêutico , Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos , Mupirocina/uso terapêutico , Rifampina/uso terapêutico , Infecções Cutâneas Estafilocócicas/tratamento farmacológico , Sulfametizol/uso terapêutico , Trimetoprima/uso terapêutico , Administração Oral , Administração Tópica , Clorexidina/uso terapêutico , Clindamicina/administração & dosagem , Combinação de Medicamentos , Humanos , Mupirocina/administração & dosagem , Rifampina/administração & dosagem , Sulfametizol/administração & dosagem , Trimetoprima/administração & dosagem
5.
Eur J Oncol Nurs ; 19(6): 724-30, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26071199

RESUMO

PURPOSE: The aims of the present study were to investigate patients' satisfaction with nurse-led clinics, patients' perception of received information and associations between continuity of care and satisfaction with information. METHODS: Questionnaires on patient satisfaction were sent to consecutive samples of patients after they attended a nurse-led clinic at the Department of Oncology, Karolinska University Hospital in 2007, 2009, 2011 and 2013. Patients' perceptions of received information were evaluated in 2011 and 2013, by the EORTC QLQ-INFO25. Data on registered continuity of care were retrieved from the patients' medical record. RESULTS: A total of 962 patients responded (79%) to one of the four surveys. Patients' satisfaction with nurse-led clinics was stable over time. More than 90% rated nurses' interpersonal manners and the care at the clinic as "good", the waiting time as "acceptable", and the length of appointments as "sufficient". Over 90% responded that it was important to meet the same nurse and 62% reported they actually did so and 52% stated they were assigned a named nurse navigator. More than 75% rated the information at their latest visit at a nurse-led clinic as "completely" sufficient. However, 48% expressed wish for more information "during the current disease". No statistical significant associations were found between "satisfaction with information" and continuity of care. CONCLUSIONS: Patients' satisfaction with nurse-led clinics was stable over time with generally high figures with the exception for continuity of care and information, areas in which improvements are needed. The wide variety in information needs might require a person-centred approach.


Assuntos
Continuidade da Assistência ao Paciente/organização & administração , Relações Enfermeiro-Paciente , Educação de Pacientes como Assunto/métodos , Satisfação do Paciente/estatística & dados numéricos , Padrões de Prática em Enfermagem/organização & administração , Adulto , Idoso , Idoso de 80 Anos ou mais , Instituições de Assistência Ambulatorial , Estudos Transversais , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Papel do Profissional de Enfermagem , Enfermagem Oncológica/métodos , Pacientes Ambulatoriais/estatística & dados numéricos , Inquéritos e Questionários , Suécia , Resultado do Tratamento
7.
Sex Transm Dis ; 40(2): 123-9, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23324975

RESUMO

BACKGROUND: Monitoring of condylomas is an early evidence of population effectiveness of human papillomavirus (HPV) vaccination programs. If reporting could include HPV typing, the contribution by vaccine HPV types to condyloma burden could be monitored. METHODS: A sentinel site for reporting of condyloma including HPV typing was established at the Centre for Sexual Health in Malmö, Sweden. In 2006 to 2009, when there were few HPV vaccines, 621 subjects with condyloma were reported and HPV genotyped. RESULTS: Ninety-four percent of the condylomas contained genital HPV types. Thirty-five different genital HPV types were identified, with HPV6 (62%), HPV16 (13%), and HPV11 (10%) being the most common. At least 1 of the 4 HPV types in the HPV6/11/16/18 vaccine was detected in 77%. High-risk HPV types were more common in females (45%) than among males (27%) (odds ratio, 1.9; confidence interval, 1.3-2.8). Extended testing among subjects initially negative for HPV found 21 patients with cutaneous types of HPV, including a novel type (HPV153). CONCLUSIONS: This report provides a baseline distribution of HPV types in condylomas before the introduction of an HPV vaccination program in this population. Human papillomavirus typing is feasible in routine condyloma reporting.


Assuntos
Alphapapillomavirus , Condiloma Acuminado/prevenção & controle , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus , Vigilância da População , Neoplasias do Colo do Útero/prevenção & controle , Adolescente , Idoso , Alphapapillomavirus/imunologia , Alphapapillomavirus/isolamento & purificação , Condiloma Acuminado/epidemiologia , Feminino , Técnicas de Genotipagem , Papillomavirus Humano 11 , Papillomavirus Humano 16 , Papillomavirus Humano 18 , Papillomavirus Humano 6 , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Papillomavirus/epidemiologia , Projetos Piloto , Saúde Pública , Suécia/epidemiologia , Neoplasias do Colo do Útero/epidemiologia , Adulto Jovem
8.
Scand J Infect Dis ; 43(6-7): 456-62, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21366406

RESUMO

BACKGROUND: The duration of colonization with methicillin-resistant Staphylococcus aureus (MRSA) is not well known and there is debate as to whether a patient colonized with MRSA ever can be defined as 'MRSA-negative'. METHODS: Since 2003 all notified MRSA cases have been systematically followed in Skåne County, southern Sweden. Cultures are taken from the nares, throat, perineum and possible skin lesions. Contact tracing is conducted. The screening program continues as long as cultures are positive and then until 1 y of consecutive negative cultures for MRSA is completed. RESULTS: Of the 578 MRSA cases during 2003-2006, 535 were included in this retrospective study. The median duration of colonization with MRSA was 5.9 months. Having household contacts with MRSA, young age, spa-type t002 and colonization in 2 or more locations, were significantly associated with a longer duration of colonization. Having a clinical infection treated with antibiotics (compared to clinical infection with no antibiotic treatment or asymptomatic carriage) was significantly associated with a shorter carriage time. Eradication treatment was associated with a shorter carriage time. CONCLUSION: These results may have implications for the management of patients with MRSA carriage. The study indicates that MRSA carriage can be defined as 'negative' in a follow-up program and shows the importance of performing contact tracing among household members.


Assuntos
Portador Sadio/microbiologia , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Infecções Estafilocócicas/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Nariz/microbiologia , Períneo/microbiologia , Faringe/microbiologia , Estudos Retrospectivos , Pele/microbiologia , Suécia , Fatores de Tempo , Adulto Jovem
10.
Scand J Infect Dis ; 39(9): 764-8, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17701713

RESUMO

In a 6-y period, 114 household contacts connected to newly diagnosed MRSA patients screened for MRSA in the southern part of Sweden. In 22 of 51 (43%) families, 1 to 4 household contact(s) connected to a MRSA patient were positive for MRSA. In the 22 families, 42 of 60 (70%) household contacts were positive for MRSA and transmission of MRSA occurred between adult couples, parents and children, grandparent and children and between siblings. Within a family, MRSA-positive family members had in all but 1 instance identical MRSA strain genotypes (spa types) making intrafamilial spread of MRSA highly probable. MRSA transmission among household contacts may contribute to the prevalence of MRSA in the community and failure to identify MRSA in household contacts may maintain MRSA colonization in an already known MRSA patient. MRSA screening of family members living in the same household as a known MRSA patient should therefore be considered.


Assuntos
Infecções Comunitárias Adquiridas/epidemiologia , Características da Família , Resistência a Meticilina , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus/crescimento & desenvolvimento , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Infecções Comunitárias Adquiridas/microbiologia , Infecções Comunitárias Adquiridas/transmissão , Transmissão de Doença Infecciosa , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Prevalência , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/transmissão , Staphylococcus aureus/genética , Staphylococcus aureus/isolamento & purificação , Suécia/epidemiologia
11.
12.
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA